Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

The French Academy of Medicine leans toward the theory that the COVID-19 virus originated in a laboratory, according to a new report published this p ...

It's that time of year when flu vaccines are becoming available in Australia. You may have received an email from your GP ...

Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...

The publication of Mr. Tufekci’s article in the Times signals a change in the wind of elite opinion. So does the publication in the Times last October of reporter Nicholas Confessore’s deeply reported ...

(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S. in 2016 ...

The event was, of course, the COVID-19 pandemic, and the bad misleading came from scientists who purposefully discredited the now widely accepted theory that the virus originated from a leak in ...